Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

UnknownOBSERVATIONAL

Enrollment

2,001

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions

Lower Leg EdemaOrthostatic Hypertension

Interventions

DRUG

Levacalm

DRUG

Valsartan/amlodipine

Trial Locations (1)

RECRUITING

LG Life Science, Seoul